Antimicrobial agents and chemotherapy

• 

  Año 2006, Vol. 50, Número 12

  • Serum and Cerebrospinal Fluid Concentrations of Linezolid in Neurosurgical Patients

    S. L. Markantonis, P. Myrianthefs

    págs. 3971-3976

    

  • Treatment and Prevention of Staphylococcus epidermidis Experimental Biomaterial-Associated Infection by Bactericidal Peptide 2

    P. H. S. Kwakman

    págs. 3977-3983

    

  • Novel Alpha Interferon (IFN-alpha) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN-alpha2b Therapy in a Subgenomic Replicon System

    Amaury Martin, D. Durantel, V. Escuret

    págs. 3984-3991

    

  • Prevalence and Genetic Analysis of Plasmid-Mediated Quinolone Resistance Determinants QnrA and QnrS in Enterobacteriaceae Isolates from a French University Hospital

    L. Poirel, C. Leviandier

    págs. 3992-3997

    

  • Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice

    M. Prot, L. Heripret, N. Cardot Leccia

    págs. 3998-4004

    

  • Biocompatibility of Solid-Dosage Forms of Anti-Human Immunodeficiency Virus Type 1 Microbicides with the Human Cervicovaginal Mucosa Modeled Ex Vivo

    R. N. Fichorova, R. T. Trifonova, J. M. Pasicznyk

    págs. 4005-4010

    

  • Efficacy of High Doses of Levofloxacin in Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus

    A. Domenech, O. Murillo

    págs. 4011-4017

    

  • Antifungal Effects on Metabolite Profiles of Medically Important Yeast Species Measured by Nuclear Magnetic Resonance Spectroscopy

    M. Coen, J. Bodkin

    págs. 4018-4026

    

  • In Vitro Activities of the Novel Oxazolidinones DA-7867 and DA-7157 against Rapidly and Slowly Growing Mycobacteria

    B. A. Brown Elliott, L. Vera Cabrera

    págs. 4027-4029

    

  • Modification of Enrofloxacin Treatment Regimens for Poultry Experimentally Infected with Salmonella enterica Serovar Typhimurium DT104 To Minimize Selection of Resistance

    S. W. Cooles, N. C. Coldham, L. J. V. Piddock, L. P. Randall, K. S. Stapleton

    págs. 4030-4037

    

  • Mutations in the E9L Polymerase Gene of Cidofovir-Resistant Vaccinia Virus Strain WR Are Associated with the Drug Resistance Phenotype

    R. S. Kornbluth

    págs. 4038-4043

    

  • LfrR Is a Repressor That Regulates Expression of the Efflux Pump LfrA in Mycobacterium smegmatis

    G. Manina, P. Guglierame, S. Buroni

    págs. 4044-4052

    

  • Mutations in Penicillin-Binding Protein (PBP) Genes and in Non-PBP Genes during Selection of Penicillin-Resistant Streptococcus gordonii

    P. Moreillon, M. Haenni

    págs. 4053-4061

    

  • Mutational Analysis of Class A and Class B Penicillin-Binding Proteins in Streptococcus gordonii

    M. Haenni, P. A. Majcherczyk

    págs. 4062-4069

    

  • A New Evolutionary Variant of the Streptogramin A Resistance Protein, Vga (A)~L~C, from Staphylococcus haemolyticus with Shifted Substrate Specificity towards Lincosamides

    G. Novotna, J. Janata

    págs. 4070-4076

    

  • Molecular Characteristics and In Vitro Susceptibility to Antimicrobial Agents, Including the Des-Fluoro(6) Quinolone DX-619, of Panton-Valentine Leucocidin-Positive Methicillin-Resistant Staphylococcus aureus Isolates from the Community and Hospitals

    T. Yamamoto

    págs. 4077-4086

    

  • In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections with Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine

    N. A. Margot, M. D. Miller, J. M. Waters

    págs. 4087-4095

    

  • Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation

    J. W. Mouton, J. P. Donnelly, A. Van Vliet, K. de Beule, A. van Peer

    págs. 4096-4102

    

  • Molecular Mechanism of a Thumb Domain Hepatitis C Virus Nonnucleoside RNA-Dependent RNA Polymerase Inhibitor

    A. Y. M. Howe

    págs. 4103-4113

    

  • Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center

    K. M. Hujer, A. M. Hujer, S. Bajaksouzian, E. A. Hulten

    págs. 4114-4123

    

  • Role of Asp 104 in the SHV beta-Lactamase

    C. R. Bethel, J. M. Thomson, M. W. Ruszczycky, A. M. Hujer, K. M. Hujer

    págs. 4124-4131

    

  • Utility of Alkylaminoquinolinyl Methanols as New Antimalarial Drugs

    T. N. Heady, G. S. Dow, A. K. Bhattacharjee

    págs. 4132-4143

    

  • Effective Prevention of Microbial Biofilm Formation on Medical Devices by Low-Energy Surface Acoustic Waves

    Z. Hazan, J. Zumeris

    págs. 4144-4152

    

  • Acyl-Substituted Dermaseptin S4 Derivatives with Improved Bactericidal Properties, Including on Oral Microflora

    K. Marynka, Y. Porat

    págs. 4153-4160

    

  • General Catalytic Deficiency of Hepatitis C Virus RNA Polymerase with an S282T Mutation and Mutually Exclusive Resistance towards 2' -Modified Nucleotide Analogues

    C. Bussetta, H. Dutartre

    págs. 4161-4169

    

  • Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones

    N. Veziris, S. Matrat

    págs. 4170-4173

    

  • Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori

    N. L. Schiller, E.M.A. Co

    págs. 4174-4176

    

  • Genetic Environment of Acquired bla~A~C~C~-~1 beta-Lactamase Gene in Enterobacteriaceae Isolates

    C. Verdet, A. Doloy, V. Gautier

    págs. 4177-4181

    

  • High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C Isolates from Infected Patients in Botswana Treated with Didanosine-Based Regimens

    F. Doualla Bell

    págs. 4182-4185

    

  • Pharmacokinetics of CS-023 (RO4908463), a Novel Parenteral Carbapenem, in Healthy Male Caucasian Volunteers

    Y. Matsushita, T. Shibayama

    págs. 4186-4188